Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

USFDA completes inspection at Dr. Reddy's Lab’s API Srikakulam plant

Date: 29-10-2019

US Food and Drug Administration (USFDA) has completed inspection at Dr. Reddy's Laboratories’ API Srikakulam Plant (SEZ) in the state of Andhra Pradesh, on October 25, 2019. The company has been issued a Form 483 with 4 observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.